Transplantation of hepatocytes or bone marrow-derived cells has been shown to ameliorate liver fibrosis in animal models, but no direct comparison of relative efficiency has been made. The aim of this study was to compare the efficiency of a bone marrow-derived clonal mesenchymal stem cell line established by us (rBM25/S3) with that of its adipogenic or hepatogenic differentiation derivative for suppression of rat liver fibrosis. After induction of differentiation of rBM25/S3 cells into adipogenic or hepatogenic cells in culture, we intrasplenically transplanted the three types of cells into rats (3 × 10 7 cells/rat) before and 4 weeks after initiation of carbon tetrachloride treatment (1 ml/kg body weight twice a week for 8 weeks) to induce liver fibrosis. Undifferentiated rBM25/S3 cells were the most effective for suppression of liver fibrosis, followed by the adipogenic cells and hepatogenic cells. Expression levels of MMP-2 and MMP-9 were also highest in undifferentiated rBM25/S3 cells. These results indicate that bone marrow-derived clonal mesenchymal stem cell lines are useful for further mechanistic studies on cell-mediated suppression of liver fibrosis and that such cell lines will provide information on an appropriate cell source for transplantation therapy for cirrhosis.
INTRODUCTION
organs limits applicability of this therapy. Thus, alternative approaches that circumvent the use of the whole organ, including transplantation of cells (34, 35) , are needed. Liver fibrosis is characterized by accumulation of extracellular matrix (ECM) proteins, including collagen, Liver fibrosis, once regarded as a relentlessly progressive abnormality, is now considered to be poten-which occurs in most types of chronic liver disease (2,7). Excess accumulation of ECM proteins results in tially reversible when the causative factors are removed (14, 33) . To facilitate resolution of fibrosis, transplanta-destruction of the hepatic tissue architecture by formation of a fibrous scar and in deterioration of the function tion of cells of various origins has been examined. Transplantation of hepatocytes was reported to improve of liver parenchymal cells, eventually leading to cirrhosis with nodules of partially regenerated hepatocytes sur-survival and/or liver function in rats with cirrhosis induced by administration of CCl 4 and phenobarbital (9, rounded by irregularly distributed fibrous septa. Liver cirrhosis affects hundred millions of people worldwide, 25, 26) . Sakaida et al. (31) reported that transplantation of freshly isolated unfractionated bone marrow cells re-and the mortality rate is steadily increasing (15) . Liver transplantation is the most drastic therapy for cirrhosis duced CCl 4 -induced liver fibrosis in mice. They indicated possible involvement of MMP-9, which was ex-with chronic hepatic failure (15) , but shortage of donor 90 HARDJO ET AL.
pressed at a high level in the bone marrow-derived cells, ated rBM25/S3(GFP) cells were the most effective for suppressing the fibrosis in the liver. in the resolution of fibers. Oyagi et al. (28) provided evidence that transplantation of bone marrow-derived MATERIALS AND METHODS mesenchymal cells cultured with HGF, but not those Reagents without HGF, improved some hepatic functions and suppressed liver fibrosis in rats injured by CCl 4 . Several Carbon tetrachloride (CCl 4 ; Wako Pure Chemical Inother studies have shown that transplantation of bone dustries, Osaka, Japan) was dissolved with olive oil at marrow-derived mesenchymal stem cells could amelioa volume ratio of 1:1. Epidermal growth factor (EGF), rate liver fibrosis (6,38), but their effects were marginal platelet-derived growth factor (PDGF)-BB (Sigma-Aldrich, or characterization of the cells used was limited. Thus, St. Louis, MO), and fibroblast growth factor (FGF)-4 it remains controversial which type(s) of cells among (R&D Systems, Minneapolis, MN) were commercially those derived from the bone marrow shows the most obtained. HGF (∆5 variant, a mature two-chain form) potent suppressive effect on fibrosis, although further was kindly provided by Daiichi Pharmaceutical (Tokyo, evidence that bone marrow cells contribute to regression Japan). Fibronectin and Matrigel were purchased from of liver fibrosis in mice has recently been provided (11, 16) .
Sigma-Aldrich and BD Sciences (Bedford, MA), respec-We recently established clonal mesenchymal stem tively. Type I collagen was prepared from tail tendons cell lines from rat bone marrow (23) . One of these cell of rats as previously described (27) . Trypsin (1:250) and lines, rBM25/S3(GFP), grew rapidly (with a doubling type I collagenase were purchased from Difco Laboratime of ϳ24 h) for at least 300 population doubling levtories (Detroit, MI) and Sigma-Aldrich, respectively. els over a period of 300 days, retaining multipotency Cell Culture to differentiate into hepatogenic, adipogenic, osteogenic, and chondrogenic lineages. When plated on Matrigel rBM25/S3(GFP) (23) cells were maintained in MAPC medium (18) , which consists of 60% DMEM (Nissui with hepatocyte growth factor and fibroblast growth factor-4, the cells differentiated into hepatocyte-like cells Pharmaceutical, Tokyo), 40% MCDB-201 (Sigma-Aldrich), 1× insulin/transferrin/selenium A containing sodium py-with a high efficiency of practically 100% within 7 days. Intrasplenic transplantation of the differentiated cells ruvate (Gibco BRL, Grand Island, NY), 1× linoleic acid/ bovine serum albumin (Sigma-Aldrich), 10 −9 M dexa-prevented fatal liver failure in 90%-hepatectomized rats, indicating exhibition of hepatic function by the cells in methasone (Banyu Pharmaceutical, Tokyo), 10 −4 M ascorbic acid 2-phosphate (Sigma-Aldrich), penicillin vivo as well. Considering the extremely high propagation potency of rBM25/S3 cells, such type of cells will (100 U/ml), streptomycin (100 µg/ml), and 2% fetal bovine serum (FBS). The cells were labeled in advance be a promising transplantation cell source if proved to have a suppressive effect on liver fibrosis. The present with green fluorescence protein (GFP) by transfecting with a plasmid pEGFP-N2 (BD Biosciences) with Trans study was undertaken to examine possible effects of rBM25/S3(GFP) and its differentiated derivatives on IT-LT1 reagent (Mirus, Madison, WI). The labeled cells showed properties very similar to those of the orig-CCl 4 -induced liver fibrosis. We found that undifferenti- inal cells. For inducing differentiation into hepatogenic suspended in PBS at 3 × 10 7 cells/0.7 ml and transplanted into the spleen of each rat under anesthesia with lineage, the cells were cultivated in MAPC medium supplemented with HGF (20 ng/ml) and FGF-4 (10 ng/ml) diethyl ether. No immunosuppressive reagent was given after the cell transplantation. All of the experiments on Matrigel as previously described (23) . For adipogenic differentiation, cells were inoculated into collagen-were performed according to the institutional ethical code for the care and use of experimental animals. coated dishes in the same medium as that described above. Cytoplasmic lipid droplets were detected by Oil Preparation of Tissues and Immunostaining Red-O staining.
For preparation of tissue sections, the animals were Induction of Liver Fibrosis With CCl 4 sacrificed with deep anesthesia and perfused via the and Transplantation of Cells heart with 4% paraformaldehyde to flush out blood cells.
The right median lobe of the liver and the spleen were Eight-week-old male Sprague-Dawley rats were injected twice a week intraperitoneally with CCl 4 (1 ml/ resected and incubated in 4% paraformaldehyde overnight. The tissues were then soaked in 30% sucrose for kg body weight as a 1:1 mixture with olive oil) for 8 weeks to induce liver fibrosis ( Fig. 1 ). rBM25/S3 and its 3 days and frozen with liquid nitrogen until preparation of tissue sections with a cryostat. differentiated derivatives were transplanted before and 4 weeks after the initial application of CCl 4 . Cells were Cultured cells or frozen tissue sections (6 µm in thickness) were fixed with cold acetone and treated with taken of five areas per section in three sections per liver selected randomly, and extent of fibrosis was estimated a primary antibody [i.e., anti-rat MMP-9 antibody (Dako, Denmark), anti-human α-SMA antibody (Chem-using an image analysis software (Scion image analyzer). icon International, Temecula, CA), or anti-GFP antibody (raised in this laboratory)], followed by a second anti-RT-PCR Analysis body, FITC-or TRITC-conjugated anti-IgG antibody Total RNA was isolated by the guanidine/thiocya-(Sigma-Aldrich). The samples were mounted with VECnate/phenol method, and 1 µg RNA was used for cDNA TASHIELD (Vector Laboratories, Burlingame, CA).
synthesis. The resulting products were amplified under Quantitative Analysis of Liver Fibrosis the following conditions: initial incubation at 94°C for 4 min followed by 30 cycles at 94°C for 30 s, 55°C for Tissue sections of the liver were stained with picrosirius red under conventional conditions. Pictures were 30 s, and 72°C for 30 s, and then a final step at 72°C
for 5 min. The primers and expected length of products activity was detected as clear bands on a blue background of the CBB-stained gel. The experiment was are shown in Table 1 . GAPDH was used as an internal control. The amplified products were subjected to elec-done in triplicate. trophoresis in 1% agarose gels and stained with ethid-Statistical Analysis ium bromide.
Data are expressed as means ± SD. Significance in Zymography difference was determined by Student's t-test following Bonferroni correction (threshold adjusted to p < 0.005). Cells were washed twice with Opti-MEM (Invitrogen, Carlsbad, CA) and further incubated in 10 ml RESULTS of the same medium for 24 h. The conditioned medium rBM25/S3(GFP) and its Differentiation Derivatives was harvested, concentrated into 100 µl by centrifugation using a Centricon (Amicon Ultra-15 Ultracell-10k; rBM25/S3(GFP) cells rapidly grew on fibronectin-Millipore, Billerica, MA), and mixed with 50 µl of 3× coated dishes in the presence of EGF and PDGF-BB SDS sample buffer. The samples (10 µl each) were ap-( Fig. 1) . They showed properties characteristic to mesplied onto 8% SDS-polyacrylamide slab gel containing enchymal stem cells with concomitant expression of 1 mg/ml gelatin (Sigma-Aldrich). After electrophoresis, some adipogenic genes at moderate levels (23) . rBM25/ the gel was washed with water to remove SDS, soaked S3(GFP) cells could be induced to differentiate into hein a protein-refolding buffer (2.5% Triton X-100, 10%
patocyte-like cells under conditions described previously glycerol, 0.5 mM CaCl 2 , 100 mM NaCl, 50 mM Tris- (23) [i.e., on Matrigel substratum with HGF (20 ng/ml) HCl/pH 7.4) for 1 h, and incubated in 50 mM Tris-HCl/ and FGF-4 (10 ng/ml)]. The cells expressed albumin, pH 7.4 containing 0.5 mM CaCl 2 for 12 h at 37°C. The cytochrome P450 (CYP) 1A1, CYP1A2, glucose 6gel was then stained with 1% Coomassie brilliant blue phosphatase, tryptophane-2,3-dioxygenase, tyrosine ami-G250. The gel was further treated with 10% methanol notransferase, hepatocyte nuclear factor (HNF) 1α, and and 5% acetic acid to destain the gel. The gelatinolytic
HNF4α. Intrasplenic transplantation of the differentiated cells prevented fatal liver failure in 90%-hepatectomized rats, indicating that the differentiated rBM25/S3(GFP) cells exhibit hepatic function in vivo as well. When rBM25/S3(GFP) cells were cultivated in the same medium but on a collagen matrix, the cells more prominently exhibited adipogenic properties (Fig. 2) . Lipid droplets progressively accumulated in the cytoplasm ( Fig. 2A) . Among the adipocyte-related genes examined, adiponectin, leptin, and resistin were newly induced when the cells were cultivated on collagen matrix (Fig. 2B ). Expression levels of G3P acyltransferase, adipocyte lipid-binding protein, adipsin, and lipoprotein lipase increased under the differentiation conditions. PPAR-γ and fatty acid synthase were expressed already in undifferentiated rBM25/S3(GFP) cells and the expression levels remained unchanged.
Suppression of Liver Fibrosis by Transplantation of rBM25/S3(GFP) Cells
It is well known that biweekly administration of CCl 4 induces severe fibrosis in the liver of rats. The treatment retarded increase of body weight during the observation period in the young rats we used (Fig. 3) . We compared effects of transplantation of the undifferentiated original rBM25/S3(GFP) and the two types of differentiated de- ipogenic cells and hepatogenic cells (Fig. 3) . Extent of liver fibrosis was examined after staining cells most effectively suppressed CCl 4 -induced liver fibrosis followed by the adipogenic and hepatogenic cells. with picrosirius red (Fig. 4) . In the control rats not treated with CCl 4 , collagen fiber was marginally ob-Difference in levels of fibrosis in each combination among the different experimental groups was statisti-served only around central veins in the liver (Fig. 4A ). Application of CCl 4 for 8 weeks resulted in marked ac-cally significant (p < 0.0001). cumulation of collagen fibers, which was nearly com-Expression of MMPs in rBM25/S3(GFP) Cells pletely abrogated by transplantation of the undifferentiin Culture and In Vivo ated rBM25/S3(GFP) cells before and 4 weeks after initiation of CCl 4 treatment ( Fig. 4C and E) . Liver fibro-Because some members of the MMP family are known to be involved in matrix remodeling and regula-sis is considered to be due to activation of hepatic stellate cells (4,8,19 ). In accordance with this notion, αtion of fibrosis in the liver (1,10,12), we examined expression of MMPs in rBM25/S3(GFP) and its differenti-smooth muscle actin, a marker of activated stellate cells, was induced in association with fiber accumulation (Fig.  ation derivatives. RT-PCR showed that undifferentiated rBM25/S3(GFP) cells expressed MMP-2, -9, and -14 4D), which was completely abrogated by transplantation of the undifferentiated rBM25/S3(GFP) cells (Fig. 4F ). (Fig. 6A ). The expression of MMP-9 in rBM25/S3(GFP) cells was confirmed by immunostaining ( Fig. 6B ). Contrary to our expectation, the cells differentiated either on collagen or on Matrigel showed a less efficient MMP-2 mRNA was detected but at lower levels in the adipogenic and hepatogenic derivatives. MMP-9 mRNA suppressive effect on the fibrosis (Figs. 4G and H) .
Quantitation of levels of fibrosis by computer-assisted
was not detected in either type of cells. Expression of MMP-14 was not affected by induction of differentia-image analysis confirmed the observation (Fig. 5) . Transplantation of the undifferentiated rBM25/S3(GFP) tion. Zymography revealed that undifferentiated rBM25/ S3(GFP) cells had a higher level of proteolytic activity of MMP-9 than did the adipogenic and hepatogenic derivatives (Fig. 6C ). Seven days after intrasplenic transplantation of undifferentiated rBM25/S3(GFP) cells, GFP and MMP-9 double-positive cells were detected in the spleen (Fig. 7A-C) . While no MMP-9-positive cells were observed in the normal liver, MMP-9-positive cells appeared in the liver of rats treated with CCl 4 for 8 weeks (Figs. 7D-I). After transplantation of undifferentiated rBM25/S3(GFP) cells, many GFP and MMP-9 double-positive cells were observed in the liver (Figs. 7J-L). These results indicate that expression of MMP-9 in the transplanted cells was sustained over the 8-week experimental period.
DISCUSSION
Liver fibrosis/cirrhosis is a complex process involving progressive degeneration of hepatic parenchymal cells, inflammation, and activation of mesenchymal cells, stellate cells in particular, resulting in aberrant accumulation of fibers (2,7,15). Because damage to hepatic parechymal cells is mostly a triggering event in human and experimental liver fibrosis, it is reasonable to expect that transplantation of hepatocytes may not only improve the hepatic function but also interfere with the vicious spiral and eventually ameliorate liver fibrosis (34) . In fact, a number of studies have shown that transplantation of hepatocytes can function to correct liver though even xenogeneic hepatocytes have been shown to survive after transplantation and to restore hepatic press liver fibrosis. It is not clear, however, whether bone marrow cells or bone marrow-derived stem cells function in certain experimental settings (25) .
Bone marrow is the most fertile tissue harboring vari-themselves have an antifibrosis function or whether they can exhibit an antifibrosis function only after differentia-ous stem cells (17, 24, 29) . Transplantation of unfractionated bone marrow cells (31) or bone marrow-derived tion into hepatocytes or some other types of cells in an in vivo environment. Bone marrow cells have been dem-mesenchymal stem cells (6,38) has been shown to sup- onstrated to differentiate into hepatocytes in vivo after their original properties. The cells can be readily differentiated into hepatocytes within 7 days with ϳ100% ef-transplantation into the liver (22, 27, 32, 37) . rBM25/S3 provides a unique opportunity for assess-ficiency. The original rBM25/S3 cells are suitable for treating liver fibrosis and their hepatogenically differen-ing relative efficiency of suppression of fibrosis among different types of cells. rBM25/S3 is a clonal cell line tiated derivative can rescue liver failure (23) . Use of the different cell types of the same clonal origin or their retaining stable properties during a propagation period of over 300 PDL (23) . When transferred onto Matrigel mixture for different pathological conditions in animal models will certainly contribute to a better understand-in a medium containing HGF and FGF-4, rBM25/S3 cells readily and homogeneously (ϳ100%) differenti-ing of the nature of liver dysfunction and to the development of new cell therapeutic strategies against various ated into hepatocyte-like cells expressing albumin and HNF4α (23) . The cells appear functional also in vivo liver diseases. because transplantation of the cells rescued 90%-hepa-ACKNOWLEDGMENTS: The authors declare that they do not tectomized rats with otherwise fatal liver failure. On a have anything to disclose regarding conflict of interest with respect to this manuscript. This work was partly supported by collagen matrix, rBM25/S3 cells showed predominantly a grant from the Ministry of Education, Culture, Sports, Sciadipogenic phenotypes (Fig. 2) . These differentiation ence and Technology (No. 18590269). events were appreciable within 4 days and fully proceeded by the 7 culture days. We compared possible REFERENCES suppression of CCl 4 -induced liver fibrosis by these three different types of cells derived form the clonal cell line. 
